Hong J, Choi R, Shim J, Kim K, Kim R, Cho H
Neuro Oncol. 2024; 27(3):654-667.
PMID: 39392921
PMC: 11889716.
DOI: 10.1093/neuonc/noae211.
Park J, Koh I, Cha J, Oh Y, Shim J, Kim H
Pharmaceuticals (Basel). 2024; 17(4).
PMID: 38675489
PMC: 11054899.
DOI: 10.3390/ph17040529.
Huang Z, Abdallah A, Shen G, Suarez M, Feng P, Yu Y
Int J Mol Sci. 2023; 24(19).
PMID: 37834154
PMC: 10572784.
DOI: 10.3390/ijms241914707.
Park J, Shim J, Lee M, Kim D, Yoon S, Moon J
Br J Cancer. 2023; 129(7):1061-1070.
PMID: 37558923
PMC: 10539507.
DOI: 10.1038/s41416-023-02391-y.
Wang Y, Zhao Y, Zhang Z, Zhang J, Xu Q, Zhou X
Genes (Basel). 2023; 14(7).
PMID: 37510310
PMC: 10380011.
DOI: 10.3390/genes14071406.
Magnetic resonance spectroscopic correlates of progression free and overall survival in "glioblastoma, IDH-wildtype, WHO grade-4".
Sacli-Bilmez B, Danyeli A, Yakicier M, Aras F, Pamir M, Ozduman K
Front Neurosci. 2023; 17:1149292.
PMID: 37457011
PMC: 10339315.
DOI: 10.3389/fnins.2023.1149292.
Exploring the Functional Roles of Telomere Maintenance 2 in the Tumorigenesis of Glioblastoma Multiforme and Drug Responsiveness to Temozolomide.
Feng S, Wu Z, Chiu Y, Huang S
Int J Mol Sci. 2023; 24(11).
PMID: 37298208
PMC: 10252701.
DOI: 10.3390/ijms24119256.
Supratentorial Sporadic Hemangioblastoma: A Case Report With Mutation Profiling Using Next-Generation DNA Sequencing.
Taher M, Bantan N, Alwalily M, Saeed M, Taher N, Bouzidi M
Cureus. 2023; 15(6):e39818.
PMID: 37273678
PMC: 10233511.
DOI: 10.7759/cureus.39818.
Mesenchymal Stem-Like Cells Derived from the Ventricle More Effectively Enhance Invasiveness of Glioblastoma Than Those Derived from the Tumor.
Park J, Lee D, Shim J, Yoon S, Moon J, Kim E
Yonsei Med J. 2023; 64(3):157-166.
PMID: 36825341
PMC: 9971438.
DOI: 10.3349/ymj.2022.0430.
Identification of Prognostic LncRNAs Subtypes Predicts Prognosis and Immune Microenvironment for Glioma.
Chen F, Peng X, Teng Z, Long H, Wu H
Evid Based Complement Alternat Med. 2022; 2022:3709823.
PMID: 36248415
PMC: 9568296.
DOI: 10.1155/2022/3709823.
Screening seven hub genes associated with prognosis and immune infiltration in glioblastoma.
Zhang Y, Fan H, Zou C, Wei F, Sun J, Shang Y
Front Genet. 2022; 13:924802.
PMID: 36035134
PMC: 9412194.
DOI: 10.3389/fgene.2022.924802.
A lignan from Alnus japonica inhibits glioblastoma tumorspheres by suppression of FOXM1.
Shim J, Lim S, Jeong J, Choi R, Oh Y, Park J
Sci Rep. 2022; 12(1):13990.
PMID: 35978012
PMC: 9385634.
DOI: 10.1038/s41598-022-18185-w.
Comprehensive Characterization of Pyroptosis Patterns with Implications in Prognosis and Immunotherapy in Low-Grade Gliomas.
Zhou Z, Wei J, Lu B, Jiang W, Bao Y, Li L
Front Genet. 2022; 12:763807.
PMID: 35198000
PMC: 8859270.
DOI: 10.3389/fgene.2021.763807.
Can Apparent Diffusion Coefficient Predict the Grade, Genotype, or Proliferation Index of Oligodendrogliomas.
Ali L, Usman K, Fatima M, Amna A, Saeed A, Qadeer S
Asian J Neurosurg. 2022; 16(4):752-758.
PMID: 35071073
PMC: 8751508.
DOI: 10.4103/ajns.AJNS_520_20.
Diagnostic Utility of the Immunohistochemical Expression of Serine and Arginine Rich Splicing Factor 1 (SRSF1) in the Differential Diagnosis of Adult Gliomas.
Broggi G, Salvatorelli L, Barbagallo D, Certo F, Altieri R, Tirro E
Cancers (Basel). 2021; 13(9).
PMID: 33925821
PMC: 8123436.
DOI: 10.3390/cancers13092086.
A Candidate Prognostic Biomarker Complement Factor I Promotes Malignant Progression in Glioma.
Cai X, Qiu W, Qian M, Feng S, Peng C, Zhang J
Front Cell Dev Biol. 2021; 8:615970.
PMID: 33614625
PMC: 7889977.
DOI: 10.3389/fcell.2020.615970.
Assessment of Amide proton transfer weighted (APTw) MRI for pre-surgical prediction of final diagnosis in gliomas.
Durmo F, Rydhog A, Testud F, Latt J, Schmitt B, Rydelius A
PLoS One. 2020; 15(12):e0244003.
PMID: 33373375
PMC: 7771875.
DOI: 10.1371/journal.pone.0244003.
Case Report: A Malignant Liver and Thoracic Solitary Fibrous Tumor: A 10-Year Journey From the Brain to the Liver and the Spine.
Mao M, Zhou L, Huang C, Yan X, Hu S, Yin H
Front Surg. 2020; 7:570582.
PMID: 33344498
PMC: 7744481.
DOI: 10.3389/fsurg.2020.570582.
Comparison of Genetic Profiles and Prognosis of High-Grade Gliomas Using Quantitative and Qualitative MRI Features: A Focus on G3 Gliomas.
Hong E, Choi S, Shin D, Jo S, Yoo R, Kang K
Korean J Radiol. 2020; 22(2):233-242.
PMID: 32932560
PMC: 7817637.
DOI: 10.3348/kjr.2020.0011.
Computational Analysis of , and Mutations in Low-Grade Gliomas Including Oligodendrogliomas and Astrocytomas.
Bendahou M, Arrouchi H, Lakhlili W, Allam L, Aanniz T, Cherradi N
Cancer Inform. 2020; 19:1176935120915839.
PMID: 32313423
PMC: 7160765.
DOI: 10.1177/1176935120915839.
